These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10778993)

  • 21. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells.
    Arancia G; Calcabrini A; Marra M; Crateri P; Artico M; Martone A; Martelli F; Agostinelli E
    Amino Acids; 2004 Jun; 26(3):273-82. PubMed ID: 15221508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
    Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW; Goldenberg S; Pastan I; Gottesman MM
    J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
    Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cytoskeleton as a subcellular target of the antineoplastic drug lonidamine.
    Malorni W; Meschini S; Matarrese P; Arancia G
    Anticancer Res; 1992; 12(6B):2037-45. PubMed ID: 1295447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
    Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C
    J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.
    Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O
    Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential changes in purine nucleotides after Doxorubicin treatment of human cancer cells in vitro.
    Walenta S; Feigk B; Wachsmuth I; Dunkern T; Degani H; Mueller-Klieser W
    Int J Oncol; 2002 Aug; 21(2):289-96. PubMed ID: 12118323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
    Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
    Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular determinants of intrinsic resistance to doxorubicin in human cancer cell lines.
    Gariboldi MB; Ravizza R; Riganti L; Meschini S; Calcabrini A; Marra M; Arancia G; Dolfini E; Monti E
    Int J Oncol; 2003 May; 22(5):1057-64. PubMed ID: 12684672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines.
    Cheng SC; Zhou J; Xie Y
    Cell Biol Int; 2005 Apr; 29(4):269-75. PubMed ID: 15914037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.
    Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
    Mol Cancer Res; 2008 Oct; 6(10):1607-20. PubMed ID: 18922976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermia enhances cytotoxicity of amine oxidase and spermine on drug-resistant LoVo colon adenocarcinoma cells.
    Agostinelli E; Belli F; Dalla Vedova L; Marra M; Crateri P; Arancia G
    Int J Oncol; 2006 Jun; 28(6):1543-53. PubMed ID: 16685455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosensitivity in multidrug-resistant and cisplatin-resistant human carcinoma cell lines.
    Gigante M; Toffoli G; Bertola A; Biscontin G; Dassie A; Zanelli GD; Zanin E; Trovò MG; Muzzio PC
    Am J Clin Oncol; 2003 Aug; 26(4):e73-9. PubMed ID: 12902902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells.
    Biroccio A; Del Bufalo D; Fanciulli M; Bruno T; Zupi G; Floridi A
    Int J Cancer; 1999 Jul; 82(1):125-30. PubMed ID: 10360831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.